(CKI) Clarke - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA1819013071

CKI: Energy, Materials, Real Estate, Manufacturing, Industrial

Clarke Inc. (TO: CKI) is a private equity and venture capital firm focused on middle-market investments, specializing in turnaround situations, PIPEs (public investments in private equity), bridge financing, recapitalization, and buyouts. The firm targets undervalued or underperforming businesses with tangible hard assets, investing in both public and private entities across various sectors, including manufacturing, industrial, energy, materials, and real estate. Clarke Inc. prioritizes investments in equity and debt securities, with a preference for well-priced equity over debt, particularly in oilfield services companies rather than exploration and production (E&P) firms. The firm actively engages in active involvement in portfolio company governance, often participating in board-level decision-making. Clarke Inc. primarily operates in Canada and the United States, with a focus on balance sheet-driven investments.

Clarke Inc. (TO: CKI) operates in the Hotels, Resorts & Cruise Lines sub-industry, though its core business revolves around private equity and venture capital investments. The firm was established in 1997 and is headquartered in Halifax, Canada. For more information, visit their official website at https://www.clarkeinc.com.

Three-Month Forecast: Based on current technical and fundamental data, Clarke Inc. (TO: CKI) is expected to experience sideways price action with potential downside risks. The stocks short-term moving averages (SMA 20: 23.02, SMA 50: 23.35) suggest resistance at the 23.00 level, while the long-term SMA 200 (22.63) indicates support near current levels. The Average True Range (ATR: 0.07) reflects low volatility, suggesting limited price movement. Fundamentally, the stock trades at a P/E of 13.23 with a P/B ratio of 1.23, indicating fair valuation. However, the lack of forward P/E data and a P/S ratio of 3.79 may signal cautious investor sentiment. Over the next three months, Clarke Inc. is likely to trade in a narrow range between 22.00 and 23.50, with potential dips below the SMA 200 if broader market conditions deteriorate.

Additional Sources for CKI Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CKI Stock Overview

Market Cap in USD 216m
Sector Consumer Cyclical
Industry Lodging
GiC Sub-Industry Hotels, Resorts & Cruise Lines
IPO / Inception

CKI Stock Ratings

Growth 5y 70.4%
Fundamental 36.2%
Dividend 8.89%
Rel. Strength Industry 3.66
Analysts -
Fair Price Momentum 22.32 CAD
Fair Price DCF 3.29 CAD

CKI Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 29.6%

CKI Growth Ratios

Growth Correlation 3m -92.8%
Growth Correlation 12m 42%
Growth Correlation 5y 98.3%
CAGR 5y 15.89%
CAGR/Max DD 5y 0.28
Sharpe Ratio 12m -0.16
Alpha 7.74
Beta -0.18
Volatility 13.08%
Current Volume 2.9k
Average Volume 20d 1.6k
What is the price of CKI stocks?
As of March 14, 2025, the stock is trading at CAD 22.19 with a total of 2,900 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -5.37%, over three months by -5.97% and over the past year by +11.23%.
Is Clarke a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Clarke (TO:CKI) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.16 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CKI as of March 2025 is 22.32. This means that CKI is currently overvalued and has a potential downside of 0.59%.
Is CKI a buy, sell or hold?
Clarke has no consensus analysts rating.
What are the forecast for CKI stock price target?
According to ValueRays Forecast Model, CKI Clarke will be worth about 24.1 in March 2026. The stock is currently trading at 22.19. This means that the stock has a potential upside of +8.65%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 24.1 8.7%